Clinical Trials
14 trialsNCT02004834 2026-05-04
Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine
University Hospital Dubrava
Phase 4 Active not recruiting
NCT06953193 2026-04-01
Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase NA Recruiting
NCT07481851 2026-03-25
Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Recruiting
NCT05738603 2025-08-03
The Hypotension Prediction Index in Free Flap Transplant in Head and Neck Surgery.
Poznan University of Medical Sciences
Phase NA Recruiting
NCT04151264 2025-03-30
Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery
University of Giessen
Phase NA Completed
NCT02018497 2023-09-21
ESSENTIAL
CES University
Unknown
NCT05354661 2022-05-31
Perioperative Hypotension in Gynaecologic Oncologic Surgery: HPI-ClearSight Versus Arterial Waveform Analysis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
NCT03882697 2020-12-21
Ability of Cardio Q for Prediction of Hypotension
Severance Hospital
Completed
NCT03215797 2018-01-23
Phenylephrine or Norepinephrine for a Better Hemodynamic Stability
The Second Affiliated Hospital of Dalian Medical University
Phase 3 Completed
NCT02811406 2016-06-23
The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites
National University Hospital, Singapore
Phase NA Unknown
NCT01593579 2014-12-23
Autonomic Phenotype Before and After Akt Inhibition
Vanderbilt University
Withdrawn
NCT01418118 2011-08-16
Free4Flow
Oxford University Hospitals NHS Trust
Phase 4 Completed
NCT00158041 2005-09-12
Subcutaneous Amifostine Safety Study
Mt. Sinai Medical Center, Miami
Phase 4 Completed
NCT00033956 2005-06-24
Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2
MetaPhore Pharmaceuticals
Phase 1/2 Suspended